Obatala Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
18
Obatala General Information
Description
Developer of an in vitro humanized adipose tissue model system designed to simplify tissue engineering for drug discovery. The company's system is a three-dimensional screening tool used for disease modeling, cell assays, cell identification, tissue analysis, and drug discovery, enabling academic and pharmaceutical researchers to identify effective drug compounds and reduce the time, money, and effort required in testing potential drugs to treat obesity, diabetes, other metabolic diseases, and related cancers.
Contact Information
Website
www.obatalasciences.comCorporate Office
- 2000 Lakeshore Drive
- Suite 4020
- New Orleans, LA 70148
- United States
Corporate Office
- 2000 Lakeshore Drive
- Suite 4020
- New Orleans, LA 70148
- United States
Obatala Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 11. Later Stage VC (Series A) | 01-Jul-2023 | Completed | Generating Revenue | |||
| 10. Later Stage VC | Cancelled | Generating Revenue | ||||
| 9. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 8. Early Stage VC | 30-Sep-2020 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 03-Jul-2020 | Completed | Startup | |||
| 6. Accelerator/Incubator | 01-Jan-2020 | Completed | Startup | |||
| 5. Grant | 25-Apr-2019 | Completed | Startup | |||
| 4. Grant | 01-Jan-2019 | $1.35M | Completed | Startup | ||
| 3. Grant | 05-Sep-2017 | $250K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Obatala Comparisons
Industry
Financing
Details
Obatala Competitors (24)
One of Obatala’s 24 competitors is Scipher Medicine, a Venture Capital-Backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Scipher Medicine | Venture Capital-Backed | Waltham, MA | ||||
| Partek | Corporate Backed or Acquired | Chesterfield, MO | ||||
| Peptone | Venture Capital-Backed | Mansfield, United Kingdom | ||||
| Biolog | Venture Capital-Backed | Hayward, CA | ||||
| GnuBIO | Formerly VC-backed | Cambridge, MA |
Obatala Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Obatala Patents
Obatala Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260335252-A1 | Cellulose nanofibril-based hydrogels containing wound healing adjuvants | Pending | 29-Apr-2025 | ||
| EP-3579844-A2 | Biological scaffolds, products containing biological scaffolds and methods of using the same | Active | 10-Feb-2017 | ||
| EP-3579844-A4 | Biological scaffolds, products containing biological scaffolds and methods of using the same | Active | 10-Feb-2017 | ||
| EP-3579844-B1 | Biological scaffolds, products containing biological scaffolds and methods of using the same | Active | 10-Feb-2017 | ||
| US-20200078411-A1 | Biological scaffolds, products containing biological scaffolds and methods of using the same | Inactive | 10-Feb-2017 | A61K35/35 |
Obatala Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Obatala Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Benson Capital Partners | Venture Capital | Minority | ||
| Charleston Angel Partners | Angel Group | Minority | ||
| Corridor Ventures (New Orleans) | Venture Capital | Minority | ||
| être Venture Capital | Venture Capital | Minority | ||
| Hackett Robertson Tobe Group | Asset Manager | Minority |
Obatala Acquisitions (1)
Obatala’s most recent deal was a Merger/Acquisition with LaCell. The deal was made on 01-Jan-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| LaCell | 01-Jan-2020 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Obatala FAQs
-
When was Obatala founded?
Obatala was founded in 2017.
-
Where is Obatala headquartered?
Obatala is headquartered in New Orleans, LA.
-
What is the size of Obatala?
Obatala has 11 total employees.
-
What industry is Obatala in?
Obatala’s primary industry is Discovery Tools (Healthcare).
-
Is Obatala a private or public company?
Obatala is a Private company.
-
What is Obatala’s current revenue?
The current revenue for Obatala is .
-
How much funding has Obatala raised over time?
Obatala has raised $4.25M.
-
Who are Obatala’s investors?
Benson Capital Partners, Charleston Angel Partners, Corridor Ventures (New Orleans), être Venture Capital, and Hackett Robertson Tobe Group are 5 of 18 investors who have invested in Obatala.
-
Who are Obatala’s competitors?
Scipher Medicine, Partek, Peptone, Biolog, and GnuBIO are some of the 24 competitors of Obatala.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
